Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential for Oral DIM Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers

NCT01022333 is registered in ClinicalTrials.gov with Women's College Hospital as lead sponsor.

NCT NCT01022333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01022333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential for Oral DIM Supplementation to Increase the Production of the BRCA1 Protein in BRCA1 Mutation Carriers
Lead sponsor
Women's College Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
July 31, 2009
Completion date
December 31, 2010
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer